Brief: TC Biopharm Announces Pricing Of Upsized $17.5 Mln IPO And Nasdaq Listing
Feb 10 (Reuters) - TC BioPharm Holdings PLC TCBP.O :
* TC BIOPHARM ANNOUNCES PRICING OF UPSIZED $17.5 MILLION
INITIAL
PUBLIC OFFERING AND NASDAQ LISTING
* TC BIOPHARM HOLDINGS - PRICING IPO OF 4.1 MILLION AMERICAN
DEPOSITARY SHARES AND WARRANTS TO PURCHASE UP TO 8.2 MILLION
ADSS
* TC BIOPHARM - ADSS AND WARRANTS WILL BE SOLD TO
PURCHASERS ONLY
IN A COMBINATION OF ONE ADS AND TWO WARRANTS, FOR COMBINED
OFFERING PRICE OF $4.25
Source text for Eikon: ID:nPn51YN8va
Further company coverage: TCBP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TC Biopharm (Holdings)
See all newsBrief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: TC BioPharm Announces Complete Response In Minimal Residual Disease Patient
Brief: TCBP Announces Non-Binding Letter Of Intent To Acquire Commercial Stage Ophthalmic Pharmaceutical Company
Brief: TC Biopharm's Data Show A Favorable Response In Patients With Relapse Or Refractory AML
Brief: TCBP Trading Continues Unabated On Nasdaq Stock Exchange